Resistomycin is an antibiotic from Streptomyces resistomycificus, formerly known as the trademark for kanamycin A sulfate. It is being assessed as an anticancer compound. It has also been tested for use as a therapeutic agent against tuberculosis. References: Carlson S, Tanouye U, Omarsdottir S, Murphy BT. Phylum-specific regulation of resistomycin production in a Streptomyces sp. via microbial coculture. J Nat Prod. 2015 Mar 27;78(3):381-7. doi: 10.1021/np500767u. Epub 2014 Dec 24. PubMed PMID: 25537064.

纯度：≥98%

CAS：20004-62-0